AcuSurgical’s Post

Seven patients have been successfully operated using the Luca™ high-precision robotics surgical platform as part of a clinical trial conducted by AcuSurgical at Ghent University Hospital under senior retinal surgeon Nerinckx Fanny. In a world first, patients with retinal disease were treated using a dual-instrument surgical robot. The success of these procedures marks a major milestone in improving treatments for these challenging conditions. The AcuSurgical team has consistently demonstrated rapid execution towards bringing their innovative robotic surgical technology to market. The company is leading the way in developing a surgical robotics platform that will be a game changer for retinal and eye surgery, promising to significantly improve the lives of millions of patients worldwide. Nerinckx Fanny Universitair Ziekenhuis Gent Merieux Equity Partners Supernova Invest UI Investissement SORIDEC Entreprendre à Montpellier LIRMM https://lnkd.in/eCaxtP8F

Eye Surgery Robotics Company AcuSurgical Successfully Completes First Clinical Study | MedTech Dive

Eye Surgery Robotics Company AcuSurgical Successfully Completes First Clinical Study | MedTech Dive

medtechdive.com

Charles Mayron MD FACS

Medical Doctor @ Retina Vitreous | Ophthalmology Residency Program

4mo

What common pathologies can robots do that human surgeons can’t do? Cannulation of vessels ?

Like
Reply

To view or add a comment, sign in

Explore topics